Kyorin Holdings Inc
TSE:4569
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (18), the stock would be worth ¥3 366.76 (116% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.3 | ¥1 558 |
0%
|
| 3-Year Average | 18 | ¥3 366.76 |
+116%
|
| 5-Year Average | 19.5 | ¥3 649.51 |
+134%
|
| Industry Average | 21.9 | ¥4 104.99 |
+163%
|
| Country Average | 17 | ¥3 187.99 |
+105%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥97.5B
|
/ |
Jan 2026
¥10.8B
|
= |
|
|
¥97.5B
|
/ |
Mar 2026
¥4.8B
|
= |
|
|
¥97.5B
|
/ |
Mar 2027
¥4.9B
|
= |
|
|
¥97.5B
|
/ |
Mar 2028
¥5.2B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Kyorin Holdings Inc
TSE:4569
|
89.5B JPY | 8.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
820.3B USD | 39.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
542.6B USD | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.7B GBP | 27.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.9B CHF | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.8B USD | 15 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.3B USD | 19.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.3B USD | 16.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 17 |
| 70th Percentile | 23 |
| Max | 7 956 708 |
Other Multiples
Kyorin Holdings Inc
Glance View
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.
